News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

Editorial: Stem cell board must find way to hold open meetings

By admin Oakland Tribune | 12.21.2004
ROBERT N. Klein, the millionaire Portola Valley real estate developer, was sworn in Friday to lead California's $3 billion venture...
Patents & Other IP

Woes for California's stem-cell experiment

By Mark Sappenfield, Christian Science Monitor | 12.20.2004
The debate over stem-cell research has been stirred again - this time by the unlikeliest of sources.

For months, state...
Stem Cells

Financier to Lead Institute on Stem Cells

By Carolyn Marshall, New York Times | 12.18.2004
SAN FRANCISCO, Dec. 17 - The real estate developer who helped write and finance a ballot initiative to create a...
Biotech & Pharma

Prop. 71 financier debuts as chairman

By Carl T. Hall, San Francisco Chronicle | 12.18.2004
29-member board sworn in; biotech exec is vice chair

Robert N. Klein, a millionaire developer with no scientific credentials but...
Stem Cells

Controversy embroils stem cell panel

By Laura Mecoy, Sacramento Bee | 12.17.2004
LOS ANGELES - The stem cell oversight committee, meeting for the first time today in San Francisco, already is embroiled...
Biotech & Pharma

The Stem Cell Chair to the Highest Bidder?

By Francine Coeytaux and Susan Berke Fogel, Los Angeles Times | 12.17.2004
Francine Coeytaux and Susan Berke Fogel are co-founders of the Pro-Choice Alliance for Responsible Stem Cell Research.


As the media...
Biotech & Pharma

Homo Respect-us: The creature genetic engineers fear most

By William Saletan, Slate | 12.17.2004
Whoever titled this week's conference on human germ-line modification "Babies by Design" was playing with fire. Maybe the event's host...
Human Genetic Modification

Sponsor Nabs Stem Cell Post

By Kristen Philipkoski, Wired | 12.17.2004
A real estate developer who spent $3 million of his own money to get the California stem cell initiative on...
Stem Cells